(Q35763447)

10 August 2017

title

CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma (English)

1 reference

10 August 2017

3

Qinghu Ren

1 reference

10 August 2017

Jonathan A Harris

1

1 reference

10 August 2017

Salvia Jain

2

1 reference

10 August 2017

Alirezah Zarineh

4

1 reference

10 August 2017

Cynthia Liu

5

1 reference

10 August 2017

Sherif Ibrahim

6

1 reference

10 August 2017

publication date

30 January 2012

1 reference

10 August 2017

1 reference

10 August 2017

volume

7

1 reference

10 August 2017

page(s)

12

1 reference

Creative Commons Attribution 2.0 Generic

10 August 2017

copyright license

start time

30 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Tumor-associated macrophages: the double-edged sword in cancer progression.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Gene expression profiling defines molecular subtypes of classical Hodgkin's disease.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3281786

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1746-1596-7-12

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22289504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22289504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1746-1596-7-12

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference